Soleno Therapeutics, Inc. - Common Stock (NQ:SLNO)

53.01 UNCHANGED

Last Price Updated: 4:00 PM EDT, May 15, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Soleno Therapeutics, Inc. - Common Stock

< Previous 1 2

...

7 8 9 10 11 12 13 14 Next >

Why CarMax Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

September 28, 2023

Gainers Bionomics Limited (NASDAQ: BNOX) shares jumped 308% to $4.00 after the company announced the ATTUNE trial met its primary endpoint showing BNC210 treatment led to a statistically significant...

Via Benzinga

Jabil, Chico's FAS And Other Big Stocks Moving Higher On Thursday ↗

September 28, 2023

U.S. stocks traded mixed, with the Dow Jones gaining around 30 points on Thursday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

Why Shares of Soleno Therapeutics Are Booming on Tuesday ↗

September 26, 2023

Soleno announced positive top-line results for DCCR, its lead therapy.

Via The Motley Fool

Soleno Therapeutics Inc. (NASDAQ: SLNO) Near the Top of Equities by Percentage Gain on 9/15

September 15, 2023

Via Investor Brand Network

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

September 28, 2023

Via Benzinga

Why Shares of Soleno Therapeutics Dropped on Wednesday ↗

September 27, 2023

Investors took profits a day after the clinical-stage biotech company's shares soared.

Via The Motley Fool

Don’t Miss the Boom: 3 ETFs Set to Explode Higher ↗

September 27, 2023

The market may be uncertain. But these three ETFs to buy are set to deliver fantastic returns regardless of the broader economic climate.

Via InvestorPlace

Topics ETFs

Why Sharps Technology Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

September 27, 2023

Gainers

Via Benzinga

Shares of Soleno Therapeutics (NASDAQ: SLNO) Surge Over 500% After Its DCCR Candidate Shows Promise in PWS Clinical Trials

September 26, 2023

Breakthrough Results from Study C602 Soleno Therapeutics, Inc. (NASDAQ: SLNO), a trailblazer in the biopharmaceutical industry, recently unveiled its promising

Via Spotlight Growth

Soleno Therapeutics' Study Outcome Bolsters Confidence In PWS Treatment ↗

September 26, 2023

Earlier on Tuesday, Soleno Therapeutics Inc (NASDAQ: SLNO) released top-line results from the randomized withdrawal period of Study C602, a long-term treatment study of DCCR (Diazoxide Choline)...

Via Benzinga

Nasdaq Down 1.5%; Immunovant Shares Spike Higher ↗

September 26, 2023

U.S. stocks traded lower toward the end of trading, with the Dow Jones falling more than 400 points on Tuesday. The Dow traded down 1.19% to 33,601.60 while the NASDAQ fell 1.48% to 13,074.97. The S&P...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

September 26, 2023

Via Benzinga

Why TD SYNNEX Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

September 26, 2023

Gainers Soleno Therapeutics, Inc. (NASDAQ: SLNO) shares jumped 318.5% to $18.54 after the company released top-line results from randomized withdrawal period of study C602 of DCCR for Prader-Willi...

Via Benzinga

Crude Oil Moves Higher; Cintas Earnings Top Estimates ↗

September 26, 2023

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 1% on Tuesday. The Dow traded down 0.96% to 33,681.79 while the NASDAQ fell 1.24% to 13,106.70. The S&P 500...

Via Benzinga

Topics Stocks

Why Is Canopy Growth (CGC) Stock Up 9% Today? ↗

September 26, 2023

Canopy Growth is in the news Tuesday after reporting results from its shareholder meeting. Approval from investors have CGC stock rising.

Via InvestorPlace

RIVN Stock Alert: Baird Expects Rivian to Outperform in Q3 ↗

September 26, 2023

Rivian Automotive stock is getting a boost from new analysts coverage of RIVN stock. That includes a positive guidance for Q3 deliveries.

Via InvestorPlace

Soleno Therapeutics Inc. (NASDAQ: SLNO) Near Top of Volume Charts in Tuesday Trading

September 26, 2023

Via Investor Brand Network

Why Is Soleno Therapeutics (SLNO) Stock Up 420% Today? ↗

September 26, 2023

Soleno Therapeutics stock is taking off on Tuesday as shares of SLNO experience heavy trading alongside positive clinical trial results!

Via InvestorPlace

Soleno Therapeutics Inc. (NASDAQ: SLNO) Sets New 52-Week High in Tuesday Session

September 26, 2023

Via Investor Brand Network

Dow Tumbles 150 Points; US House Prices Rise in July ↗

September 26, 2023

U.S. stocks traded lower this morning, with the Dow Jones falling around 150 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.45% to 33,852.58 while the NASDAQ fell 0.74%...

Via Benzinga

Topics Stocks

Soleno Catapults Almost 400% After Its Pill Controls Hunger In Obesity-Causing Genetic Disease ↗

September 26, 2023

The company is working on a treatment for Prader Willi syndrome, a disease that causes increased hunger.

Via Investor's Business Daily

Genetic Disorder Focused Soleno Therapeutics' Stock Is Trading 4X Today - Here's Why? ↗

September 26, 2023

Soleno Therapeutics Inc (NASDAQ: SLNO) released top-line results from the randomized withdrawal period of Study C602, a long-term treatment study of DCCR (Diazoxide Choline) Extended-Release tablets...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

September 26, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

September 15, 2023

Via Benzinga

Oppenheimer Maintains Outperform Rating for Soleno Therapeutics: Here's What You Need To Know ↗

September 15, 2023

Via Benzinga

Why Novonix Shares Are Trading Higher By 27%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

September 15, 2023

Gainers MSP Recovery, Inc. (NASDAQ: LIFW) shares jumped 127.8% to $0.1269. The company recently reported second-quarter results.

Via Benzinga

Keep The Hunger On: Analyst Says Soleno Therapeutics' Upside Potential Much Higher Than Downside Risk ↗

July 11, 2023

Cantor Fitzgerald has initiated coverage on Soleno Therapeutics Inc (NASDAQ: SLNO) with an Overweight rating and a

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 11, 2023 ↗

July 11, 2023

Via Benzinga

7 Top Short-Squeeze Candidates to Watch in February ↗

February 01, 2023

For those that want to zig while others zag, these heavily targeted stocks represent the top short-squeeze candidates to watch this month.

Via InvestorPlace

Kala Pharmaceuticals, Getty Images And This Bitcoin Stock Top Short Squeeze Leaderboard: 10 Short Squeeze Stocks To Watch ↗

January 17, 2023

Potential short squeeze plays gained steam in 2021 and continued through 2022, with new traders looking for the next huge move. High short interest and a high cost to borrow are among the common traits...

Via Benzinga

< Previous 1 2

...

7 8 9 10 11 12 13 14 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.